World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
AbbVie’s Expensive Growth Tonic
Keywords:
AbbVie acquisitions
03/05/2015
Grouped Articles
AbbVie to Buy Pharmacyclics in $21 Billion Deal
Wall Street Journal 03/05/2015
Biotech Bidding War Yields Rich Price
Wall Street Journal 03/06/2015
AbbVie’s Expensive Growth Tonic
Wall Street Journal 03/06/2015
AbbVie Wins Bidding War for Maker of Cancer Drug, Then Goes on Defensive
New York Times 03/05/2015
FDA Warns of Liver Damage from AbbVie’s Hepatitis C Treatments
Wall Street Journal 10/23/2015
AbbVie performance
12/18/2014
Grouped Articles
AbbVie Pins Hopes on Hepatitis C Treatment
Wall Street Journal 12/18/2014
AbbVie to Buy Pharmacyclics in $21 Billion Deal
Wall Street Journal 03/05/2015
Biotech Bidding War Yields Rich Price
Wall Street Journal 03/06/2015
AbbVie’s Expensive Growth Tonic
Wall Street Journal 03/06/2015
AbbVie Wins Bidding War for Maker of Cancer Drug, Then Goes on Defensive
New York Times 03/05/2015
FDA Warns of Liver Damage from AbbVie’s Hepatitis C Treatments
Wall Street Journal 10/23/2015
AbbVie's acquisition of Pharmacyclics for $21 billion
03/05/2015
Grouped Articles
Biotech Bidding War Yields Rich Price
Wall Street Journal 03/06/2015
How Much Is One Cancer Drug Worth?
Wall Street Journal 03/06/2015
AbbVie’s Expensive Growth Tonic
Wall Street Journal 03/06/2015
AbbVie Wins Bidding War for Maker of Cancer Drug, Then Goes on Defensive
New York Times 03/05/2015
AbbVie management
12/18/2014
Grouped Articles
AbbVie Pins Hopes on Hepatitis C Treatment
Wall Street Journal 12/18/2014
AbbVie to Buy Pharmacyclics in $21 Billion Deal
Wall Street Journal 03/05/2015
Biotech Bidding War Yields Rich Price
Wall Street Journal 03/06/2015
AbbVie’s Expensive Growth Tonic
Wall Street Journal 03/06/2015
AbbVie Wins Bidding War for Maker of Cancer Drug, Then Goes on Defensive
New York Times 03/05/2015
FDA Warns of Liver Damage from AbbVie’s Hepatitis C Treatments
Wall Street Journal 10/23/2015
AbbVie strategies
12/18/2014
Grouped Articles
AbbVie Pins Hopes on Hepatitis C Treatment
Wall Street Journal 12/18/2014
AbbVie to Buy Pharmacyclics in $21 Billion Deal
Wall Street Journal 03/05/2015
Biotech Bidding War Yields Rich Price
Wall Street Journal 03/06/2015
AbbVie’s Expensive Growth Tonic
Wall Street Journal 03/06/2015
AbbVie Wins Bidding War for Maker of Cancer Drug, Then Goes on Defensive
New York Times 03/05/2015
FDA Warns of Liver Damage from AbbVie’s Hepatitis C Treatments
Wall Street Journal 10/23/2015
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us